{
  "company": "CIPLA",
  "report_date": "August 15, 2023",
  "filename": "CIPLA_transcript_Aug_2023.pdf",
  "quarter": "Q10",
  "fiscal_year": "2023",
  "management_team": [
    "Management information not found"
  ],
  "moderator": "Dear shareholders, good afternoon and a warm welcome to the 87th Annual \nGeneral Meeting of Cipla Limited",
  "analysts": [],
  "qa_segments": [],
  "key_financial_metrics": {
    "ebitda_margin_percentage": "23"
  },
  "business_highlights": [
    "launched new products 81, 93 and 78 year-on-year, but why 15 products \nshort in â€™22- '23, what is the reason.",
    "partnership with Novartis for Scapho, which is a \npsoriasis product."
  ],
  "extraction_metadata": {
    "extraction_date": "2025-08-03T01:08:51.241758",
    "source_file": "data\\cipla\\CIPLA_transcript_Aug_2023.pdf",
    "text_length": 98930,
    "extraction_method": "PyMuPDF + Regex parsing + Filename analysis"
  }
}